Seongnam, South Korea

Jeongmin Seo

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Sk Chemicals Co., Ltd.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeongmin Seo. Retrieved from https://idiyas.com/inventor/jeongmin-seo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jeongmin Seo: Innovator in Tricyclic Compounds

Introduction

Jeongmin Seo is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on tricyclic compounds. His research focuses on compounds that can effectively control GPR40, which is crucial for the treatment of various diseases, including diabetes.

Latest Patents

Jeongmin Seo holds a patent for a tricyclic compound and its uses. The patent describes a compound selected from a group consisting of a tricyclic compound with a specific structure, along with its pharmaceutically acceptable salts, isomers, solvates, and precursors. This compound has shown promise in the prophylaxis and treatment of diseases associated with GPR40.

Career Highlights

Seo is currently associated with Sk Chemicals Co., Ltd., where he continues to advance his research and development efforts. His work has the potential to impact the pharmaceutical industry significantly, particularly in the management of diabetes and related conditions.

Collaborations

Jeongmin Seo collaborates with talented colleagues, including Ju Young Lee and Jeong A Lee, to further enhance the scope and application of his research.

Conclusion

Jeongmin Seo's innovative work in the field of tricyclic compounds exemplifies the importance of research in developing effective treatments for chronic diseases. His contributions are paving the way for advancements in pharmaceutical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…